Article
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates.
Xenon Genetics Research, Xenon Genetics Inc., Burnaby, British Columbia V5G 4W8, Canada.
The American Journal of Human Genetics (impact factor:
10.6).
06/2004;
74(5):1064-73.
DOI:10.1086/420795
pp.1064-73
Source: PubMed
-
Article: Four siblings with type II hereditary sensory and autonomic neuropathy.
Indian pediatrics 10/2002; 39(9):870-4. · 1.05 Impact Factor -
Article: Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I.
[show abstract] [hide abstract]
ABSTRACT: Hereditary sensory neuropathy type I (HSN1) is the most common hereditary disorder of peripheral sensory neurons. HSN1 is an autosomal dominant progressive degeneration of dorsal root ganglia and motor neurons with onset in the second or third decades. Initial symptoms are sensory loss in the feet followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic skin ulcers and distal amputations. The HSN1 locus has been mapped to chromosome 9q22.1-22.3 (refs. 3,4). Here we map the gene SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, to this locus. Mutation screening revealed 3 different missense mutations resulting in changes to 2 amino acids in all affected members of 11 HSN1 families. We found two mutations to be located in exon 5 (C133Y and C133W) and one mutation to be located in exon 6 of SPTLC1 (V144D). All families showing definite or probable linkage to chromosome 9 had mutations in these two exons. These mutations are associated with increased de novo glucosyl ceramide synthesis in lymphoblast cell lines in affected individuals. Increased de novo ceramide synthesis triggers apoptosis and is associated with massive cell death during neural tube closure, raising the possibility that neural degeneration in HSN1 is due to ceramide-induced apoptotic cell death.Nature Genetics 04/2001; 27(3):309-12. · 35.53 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
5-cM genome scan
8.4. Haplotype sharing
autonomic neuropathy
autosomal recessive disorder
candidate interval
conserved ORF corresponding
different truncating mutations
families
HSN2 protein
isolated population
large pedigrees segregating
Linkage analysis
maximum LOD score
Newfoundland
Nova Scotia
peripheral sensory neurons
rural Quebec
supporting Schwann cells
touch sensation